Immunology
Blood Biomarker Predicts Guillain-Barré Prognosis
Guillain-Barré syndrome (GBS) is a rare, autoimmune disorder in which a person’s own immune system damages the nerves, causing muscle weakness and sometimes paralysis. GBS can cause symptoms that last for a few weeks to several years. Most people recover fully, but some have permanent nerve damage. More...25 Nov 2020
CD200 Expression Marks Leukemia Stem Cells in Human AML
Acute myeloid leukemia (AML) is organized as a hierarchy sustained by a minor population of leukemia stem cells (LSCs) with self-renewal capacity that drive disease. The LSC populations of AML exhibit phenotypic, genetic, and functional heterogeneity that contribute to therapy failure and relapse. More...17 Nov 2020
Rapid Tests Evaluated in the Management of Dengue Fever
Dengue is a mosquito-borne infection caused by four distinct viruses (DENV 1-4) which belong to the flavivirus genus and may lead to diverse outcomes. The disease can be asymptomatic in about 75% of cases, causing Dengue fever (DF), or result in severe dengue. Dengue is common in more than 120 countries. More...12 Nov 2020
Autoantibody Timing Predicts Genetically At-Risk Children for Diabetes
While antibodies are molecules produced by the body's immune system to detect and destroy specific viruses, bacteria and other harmful substances, autoantibodies are antibodies that target a person's own healthy tissue. In the case of type 1 diabetes (T1D), a misdirected autoimmune response attacks the pancreas and gradually destroys the organ's insulin-producing beta cells. More...11 Nov 2020
Novel Fecal Calprotectin Test Validated in Pediatric Population
Inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) are increasingly prevalent disorders with overlapping clinical presentations. Distinguishing between these two classes of disease is important, as while IBS is an idiopathic functional disorder, IBD is characterized by chronic inflammation and tissue destruction. More...10 Nov 2020
Serum-IgG Responses in Patients with Mild and Severe COVID-19
The coronavirus disease 2019 (COVID-19) pandemic continues, causing considerable morbidity and mortality worldwide. The severity of COVID-19 ranges from asymptomatic to fatal pneumonitis, with mildly symptomatic patients accounting for approximately 80% of all cases according to current understanding. More...04 Nov 2020
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager
New
Human Insulin CLIA
Human Insulin CLIA Kit
In Other News
Antibodies Against Rabies Detected in Human Dried Blood Spots
Inherited Causes of Clonal Hematopoiesis in Multiplicity of Whole Genomes
Novel Method Reclaims Resolution of Single-Cell RNA-Seq
Methods for Automated Anti-Neutrophil Cytoplasmic Antibodies Compared
New Diagnostic Tests for Rotavirus and Norovirus Infections Evaluated
Lymphocytic Infiltration Explored as Biomarker for Stable Colorectal Tumors
MAIT Cell Activation Dynamics Associated with COVID-19 Disease Severity
Serum Thyroglobulin Assays Compared for Differentiated Thyroid Carcinoma
Performance Compared for Three Ebola Rapid Diagnostic Tests
Mannose-Binding Lectin Associated with Coagulopathy in Severe COVID-19
Click Chip’ Detects Early-Stage Liver Cancer Biomarkers in Extracellular Vesicles
Unique Antibody Profile Differentiates Gluten Sensitivity from Celiac Disease
Unconventional T Cells in COVID-19 Patients Predicts Disease Outcome
New Gold and Copper Nanoshell-Enhanced Immunoblotting Technique Makes POC Diagnosis of Tuberculosis Easier
Six Biomarkers Predict Severity of COVID-19
Specificity of Rheumatoid Factor Detected by Latex Fixation Compared
Adaptive Immune Cells in Ulcerative Colitis Revealed by Single-Cell Analyses
Cancer-Associated T Cell Receptors Evaluated for Malignancy Detection
Hodgkin Lymphoma Therapy Response Linked to T-Cell Receptor Repertoire
Microfluidic Device Explores Ovarian Cancer Interactions
Blood Bank NAT-Based Assay Prevents Transfusion-Transmitted Malaria
Prostate Cancer Identified By Profiling Immune Cell Subsets
Circulating tumor DNA Test Predicts Immunotherapy Response
The Immunology channel of LabMedica deals with diagnostic techniques and immuonassays such as ELISA, pregnancy tests, immunoblotting, immunohistochemical staining, serology, and associated hardware.